Type II diabetes as an example - using long-acting insulin combined with oral hypoglycemic agents, the effectiveness of converting mixed insulin
碩士 === 亞洲大學 === 生物資訊學系碩士在職專班 === 98 === Diabetes has become Taiwan's fifth leading cause of death.If poorly controlled, diabetes will cause many complications which are huge burden for medical expenses. The current NHI needs to consider the cost, and it is the goal to reduce the existing drug c...
Main Authors: | , |
---|---|
Other Authors: | |
Format: | Others |
Language: | zh-TW |
Published: |
2010
|
Online Access: | http://ndltd.ncl.edu.tw/handle/09643024892114863441 |
id |
ndltd-TW-098THMU4112014 |
---|---|
record_format |
oai_dc |
spelling |
ndltd-TW-098THMU41120142015-11-02T04:04:17Z http://ndltd.ncl.edu.tw/handle/09643024892114863441 Type II diabetes as an example - using long-acting insulin combined with oral hypoglycemic agents, the effectiveness of converting mixed insulin 第二型糖尿病為例-使用長效型胰島素合併口服降血糖藥物轉換混合型胰島素之成效 CHEN CHENG HUNG 陳政宏 碩士 亞洲大學 生物資訊學系碩士在職專班 98 Diabetes has become Taiwan's fifth leading cause of death.If poorly controlled, diabetes will cause many complications which are huge burden for medical expenses. The current NHI needs to consider the cost, and it is the goal to reduce the existing drug cost and achieve the best treatment. The control of diabetes should be a positive control, and good blood glucose control can reduce complications that can make health insurance medical savings sustainable development. The treatment of type II diabetes, long-acting insulin based drug control with oral hypoglycemic for the patients of poor blood glucose control is converted to twice daily premixed insulin control, which is better compared with blood sugar control effects, and costs of drug spending. LI GUI REN 李桂仁 2010 學位論文 ; thesis 49 zh-TW |
collection |
NDLTD |
language |
zh-TW |
format |
Others
|
sources |
NDLTD |
description |
碩士 === 亞洲大學 === 生物資訊學系碩士在職專班 === 98 === Diabetes has become Taiwan's fifth leading cause of death.If poorly controlled, diabetes will cause many complications which are huge burden for medical expenses. The current NHI needs to consider the cost, and it is the goal to reduce the existing drug cost and achieve the best treatment.
The control of diabetes should be a positive control, and good blood glucose control can reduce complications that can make health insurance medical savings sustainable development. The treatment of type II diabetes, long-acting insulin based drug control with oral hypoglycemic for the patients of poor blood glucose control is converted to twice daily premixed insulin control, which is better compared with blood sugar control effects, and costs of drug spending.
|
author2 |
LI GUI REN |
author_facet |
LI GUI REN CHEN CHENG HUNG 陳政宏 |
author |
CHEN CHENG HUNG 陳政宏 |
spellingShingle |
CHEN CHENG HUNG 陳政宏 Type II diabetes as an example - using long-acting insulin combined with oral hypoglycemic agents, the effectiveness of converting mixed insulin |
author_sort |
CHEN CHENG HUNG |
title |
Type II diabetes as an example - using long-acting insulin combined with oral hypoglycemic agents, the effectiveness of converting mixed insulin |
title_short |
Type II diabetes as an example - using long-acting insulin combined with oral hypoglycemic agents, the effectiveness of converting mixed insulin |
title_full |
Type II diabetes as an example - using long-acting insulin combined with oral hypoglycemic agents, the effectiveness of converting mixed insulin |
title_fullStr |
Type II diabetes as an example - using long-acting insulin combined with oral hypoglycemic agents, the effectiveness of converting mixed insulin |
title_full_unstemmed |
Type II diabetes as an example - using long-acting insulin combined with oral hypoglycemic agents, the effectiveness of converting mixed insulin |
title_sort |
type ii diabetes as an example - using long-acting insulin combined with oral hypoglycemic agents, the effectiveness of converting mixed insulin |
publishDate |
2010 |
url |
http://ndltd.ncl.edu.tw/handle/09643024892114863441 |
work_keys_str_mv |
AT chenchenghung typeiidiabetesasanexampleusinglongactinginsulincombinedwithoralhypoglycemicagentstheeffectivenessofconvertingmixedinsulin AT chénzhènghóng typeiidiabetesasanexampleusinglongactinginsulincombinedwithoralhypoglycemicagentstheeffectivenessofconvertingmixedinsulin AT chenchenghung dìèrxíngtángniàobìngwèilìshǐyòngzhǎngxiàoxíngyídǎosùhébìngkǒufújiàngxuètángyàowùzhuǎnhuànhùnhéxíngyídǎosùzhīchéngxiào AT chénzhènghóng dìèrxíngtángniàobìngwèilìshǐyòngzhǎngxiàoxíngyídǎosùhébìngkǒufújiàngxuètángyàowùzhuǎnhuànhùnhéxíngyídǎosùzhīchéngxiào |
_version_ |
1718120249969082368 |